Evidence map›Paper›PMID 39770576›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Effect of Homologous and Heterologous Booster in COVID-19 Vaccination.

Marija Vukčević, Mateja Despot, Aleksandra Nikolić-Kokić, Duško Blagojević, Milan Nikolić, Ana Banko, Tanja Jovanović, Dragana Despot

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marija VukčevićInstitute for Biocides and Medical Ecology, Trebevićka 16, 11030 Belgrade, Serbia.ORCID 0000-0002-7540-0215
Mateja DespotFaculty of Medicine, University of Belgrade, dr Subotića 8, 11000 Belgrade, Serbia.
Aleksandra Nikolić-KokićDepartment of Physiology, Institute for Biological Research "Siniša Stanković"-National Institute of Republic of Serbia, University of Belgrade, Despota Stefana 142, 11000 Belgrade, Serbia.ORCID 0000-0002-1116-2035
Duško BlagojevićDepartment of Physiology, Institute for Biological Research "Siniša Stanković"-National Institute of Republic of Serbia, University of Belgrade, Despota Stefana 142, 11000 Belgrade, Serbia.ORCID 0000-0001-6338-2833
Milan NikolićFaculty of Chemistry, Department of Biochemistry, University of Belgrade, Studentski trg 12-16, 11158 Belgrade, Serbia.ORCID 0000-0003-0932-889X
Ana BankoFaculty of Medicine, University of Belgrade, dr Subotića 8, 11000 Belgrade, Serbia.ORCID 0000-0002-6829-096X
Tanja JovanovićInstitute for Biocides and Medical Ecology, Trebevićka 16, 11030 Belgrade, Serbia.ORCID 0009-0002-0636-2048
Dragana DespotInstitute for Biocides and Medical Ecology, Trebevićka 16, 11030 Belgrade, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-S1 IgG antibodiesCOVID-19PfizerSinopharmSputnik vaccine

Identifiers

PMID39770576
PMCPMC11679259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.